Synthesis and Evaluation of Oligodeoxynucleotides Containing 3′-O-Ethyl-4′-C-(hydroxymethyl)thymidine: Introduction of a Novel Class of Phosphodiester Internucleoside Linkages
摘要:
3'-O-Ethyl-4'-C-(hydroxymethyl)thymidine (5) was synthesized and converted into the phosphoramidite building block 8. Novel oligodeoxynucleotide analogues containing 4'-C-hydroxymethyl phosphodiester internucleoside linkages were synthesized on an automated DNA-synthesizer. The hybridization properties and enzymatic stability were studied on oligomers with one to four modifications. The 3'-end modified oligodeoxynucleotides were resistent towards 3'-exonuclease degradation and showed only moderate lowered affinity towards complementary DNA compared with oligodeoxynucleotides bearing modifications in the middle.
Synthesis and Evaluation of Oligodeoxynucleotides Containing 3′-O-Ethyl-4′-C-(hydroxymethyl)thymidine: Introduction of a Novel Class of Phosphodiester Internucleoside Linkages
摘要:
3'-O-Ethyl-4'-C-(hydroxymethyl)thymidine (5) was synthesized and converted into the phosphoramidite building block 8. Novel oligodeoxynucleotide analogues containing 4'-C-hydroxymethyl phosphodiester internucleoside linkages were synthesized on an automated DNA-synthesizer. The hybridization properties and enzymatic stability were studied on oligomers with one to four modifications. The 3'-end modified oligodeoxynucleotides were resistent towards 3'-exonuclease degradation and showed only moderate lowered affinity towards complementary DNA compared with oligodeoxynucleotides bearing modifications in the middle.
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes
作者:Alexander Hampton、Ram R. Chawla、Francis Kappler
DOI:10.1021/jm00348a007
日期:1982.6
eight positions of thymidine (TdR) have been examined as inhibitors of rat mitochondrial (M-TK) and cytoplasmic (C-TK) isozymes of thymidine kinase. A C-TK (pI = 7.5) and an M-TK (pI = 5.1) from rat spleen were purified to apparent isozymic homogeneity by isoelectric focusing. Affinities relative to that of TdR for the TdR sites of the isozymes were derived by dividing the Michaelis constants of TdR
MCGUIGAN, C.;NICHOLLS, S. R.;OCONNOR, T. J.;KINCHINGTON, D., ANTIVIRAL CHEM. AND CHEMOTHER., 1,(1990) N, C. 25-33
作者:MCGUIGAN, C.、NICHOLLS, S. R.、OCONNOR, T. J.、KINCHINGTON, D.
DOI:——
日期:——
METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING
申请人:DARWIN MOLECULAR CORPORATION
公开号:EP0767842A1
公开(公告)日:1997-04-16
[EN] METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING<br/>[FR] PROCEDES DE CRIBLAGE D'ANALOGUES DE NUCLEOSIDES INCORPORES PAR LA TRANSCRIPTASE INVERSE DU VIH ET PROVOQUANT UN APPARIEMENT INCORRECT ENTRE BASES
申请人:LOEB, Lawrence, A.
公开号:WO1996000797A1
公开(公告)日:1996-01-11
(EN) Methods and compositions related to HIV are disclosed. Using the methods of the present invention, nucleoside analogs may be screened for the ability to be incorporated by reverse transcriptase of human immunodeficiency virus ('HIV RT') and cause incorrect base pairing. Progressive mutation of the virus by such nucleoside analogs renders it non-viable.(FR) L'invention concerne des procédés et des compositions relatifs au VIH. Selon les procédés de l'invention, on peut cribler des analogues de nucléosides afin de déterminer leur capacité à être incorporés par la transcriptase inverse du virus d'immunodéficience humaine et provoquer un appariement incorrect entre bases. La mutation progressive du virus induite par de tels analogues de nucléosides permet de le rendre non viable.
[EN] METHOD FOR AMPLIFYING UNKNOWN DNA SEQUENCE ADJACENT TO KNOWN SEQUENCE<br/>[FR] PROCEDE PERMETTANT D'AMPLIFIER UNE SEQUENCE D'ADN INCONNUE ADJACENTE A UNE SEQUENCE CONNUE
申请人:SEEGENE INC
公开号:WO2005045073A1
公开(公告)日:2005-05-19
The present invention relates to a method for amplifying an unknown nucleotide sequence adjacent to a known nucleotide sequence, which comprises the step of (a) performing a primary amplification of said unknown nucleotide sequence using a DNA walking annealing control primer (DW-ACP) and a first target-specific primer; in which said step (a) comprises: (a-1) performing a first-stage amplification of said unknown nucleotide sequence at a first annealing temperature, comprising at least one cycle of primer annealing, primer extending and denaturing using a first degenerate DW-ACP containing a degenerate random nucleotide sequence to hybridize with said unknown nucleotide sequence and a hybridizing nucleotide sequence substantially complementary to a site on said unknown nucleotide sequence; and (a-2) performing a second-stage amplification at a second annealing temperature to render said first degenerate DW-ACP not to function as a primer.